Novo Nordisk (NVO), the maker of the popular GLP-1 medications Wegovy and Ozempic, said potential tariffs on Europe imposed ...

A radical plan by a former Trump aide seeks to encourage obese Americans to lose weight—by helping their wallet. Robert P.

Only 13 states provide coverage under Medicaid for weight loss purposes. To make them more accessible, then-President Joe Biden recently proposed that Medicare and Medicaid cover them, but now that ...

President-elect Donald Trump’s quest to buy Greenland from Denmark could make Ozempic and Wegovy, the weight-loss and diabetes drugs exploding in popularity, even more expensive for Americans.

Weight-loss drug developer Metsera has raised $275 million after pricing its U.S. initial public offering at $18 per share, above its targeted range, the ARCH Venture Partners-backed biotech company ...

President-elect Donald Trump’s threat to slap Denmark with tariffs to force its hand in giving up Greenland could lead to higher prices for popular weight-loss drugs Ozempic and Wegovy as well ...

AdvaMed, the largest medical device association globally, urged the Trump administration to exempt medical products from the ...

Although ending the program won’t be easy since it requires authorization from Congress, recent moves by President-elect Donald Trump’s allies ... so making weight loss drugs more affordable ...

Trump threatened "very high" tariffs on Denmark amid Greenland dispute, raising fears of higher prices for Danish pharmaceuticals.